経皮吸収パッチ市場：製品タイプ、技術、用途、流通チャネル、エンドユーザー別-2025年～2030年世界予測

経皮吸収パッチ市場は、2023年に85億7,000万米ドルと評価され、2024年には98億9,000万米ドルに達すると予測され、CAGR 16.40％で成長し、2030年には248億4,000万米ドルになると予測されています。

経皮吸収パッチは、皮膚から薬剤を送達する粘着パッチであり、長期間にわたって血流への安定した制御放出を保証します。非侵襲性、患者のコンプライアンス向上、消化器系をバイパスする能力により、嚥下困難な患者や特定の投薬が必要な患者に適していることから、不可欠な存在となっています。疼痛管理やニコチン離脱からホルモン補充療法や慢性疾患治療まで、その治療範囲は多岐にわたる。最終用途には主にヘルスケア施設、クリニック、在宅医療環境が含まれます。経皮吸収パッチ市場の成長は、主に慢性疾患の増加、経皮ドラッグデリバリーシステムの採用増加、パッチ技術の進歩によってもたらされます。新たなビジネスチャンスは、投与量モニタリング用センサーのようなスマート技術の統合や、特定の患者のニーズをターゲットにした個別化医療アプローチにあります。企業は、薬剤を送達するだけでなくバイタルサインをモニターするパッチなど、多機能を備えたパッチを開発するための研究開発に投資することで利益を得られるかもしれないです。限界としては、皮膚刺激性の問題、特定の薬物に対する限定的な透過性、患者による皮膚吸収のばらつきなどがあり、有効性に対する課題となっています。さらに、新しい経皮吸収システムの規制上の承認は、安全性への懸念から厳しく、製品上市を遅らせる可能性があります。市場競争は激しく、主要企業はポートフォリオの拡大と地理的プレゼンスに注力しています。革新のチャンスは、パッチの粘着性を向上させ皮膚反応を最小限に抑える生体適合性素材や、現在まだ十分に普及していない生物製剤の経皮デリバリー・オプションの開発に存在します。動向としては、より包括的なドラッグデリバリー方法のために、経皮吸収パッチと注射剤成分を組み合わせたハイブリッドシステムへのシフトが見られます。市場の性質は、技術の進歩や消費者の嗜好の進化によってダイナミックに変化しており、経皮吸収型テープ製剤業界の持続的な成長と競争優位のためには、継続的な技術革新と適応が不可欠です。

市場力学：急速に進化する経皮吸収パッチ市場の主要市場インサイトを公開

経皮吸収パッチ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の治療に使用される経皮吸収パッチの世界の増加
  • 薬物放出制御および非侵襲ドラッグデリバリーソリューションへの嗜好の高まり
  • 経皮吸収パッチの政府認可数の増加
• 市場抑制要因
  • 経皮吸収パッチに関連する高コスト
• 市場機会
  • 高度で効率的な経皮ドラッグデリバリーパッチの研究開発の進行
  • 経皮吸収パッチの製剤化と製造における新たな進歩
• 市場の課題
  • 製品リコールに伴う経皮吸収型製剤の限界

ポーターのファイブフォース：経皮吸収パッチ市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：経皮吸収パッチ市場における外部からの影響の把握

外部マクロ環境要因は、経皮吸収パッチ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析経皮吸収パッチ市場における競合情勢の把握

経皮吸収パッチ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス経皮吸収パッチ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、経皮吸収パッチ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患の治療に経皮吸収パッチの使用が増加
    • 制御された薬物放出と非侵襲的なドラッグデリバリーソリューションへの関心の高まり
    • 経皮吸収パッチの政府承認数の増加
  • 抑制要因
    • 経皮吸収パッチに関連する高コスト
  • 機会
    • 先進的で高効率な経皮ドラッグデリバリーパッチの継続的な研究開発
    • 経皮吸収パッチの処方と製造における新たな進歩
  • 課題
    • 経皮吸収型医薬品の制限と製品リコール
• 市場セグメンテーション分析
  • 製品：多層薬剤接着パッチの顕著な浸透
  • タイプ：ニコチンの広範な要件経皮吸収パッチ
  • 技術：経皮パッチの効能を高める化学増強剤の利用
  • 用途：ホルモン療法における経皮吸収パッチの利用拡大
  • 流通チャネル：電子商取引プラットフォームにおける経皮吸収パッチの普及
  • エンドユーザー：病院での経皮吸収パッチの処方増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 経皮吸収パッチ市場：製品別

• マトリックス
• 多層薬剤内接着剤
• 貯水池
• 単層薬剤含有接着剤

第7章 経皮吸収パッチ市場：タイプ別

• ブプレノルフィン経皮パッチ
• クロニジン経皮パッチ
• フェンタニル経皮パッチ
• ニコチン経皮パッチ
• オキシブチニン経皮パッチ

第8章 経皮吸収パッチ市場：技術別

• 化学強化剤
• 電流
• 機械アレイ
• 熱アブレーション

第9章 経皮吸収パッチ市場：用途別

• ホルモン療法
• 過活動膀胱
• 痛みの緩和
• 喫煙の減少と禁煙の支援

第10章 経皮吸収パッチ市場：流通チャネル別

• オフライン
• オンライン

第11章 経皮吸収パッチ市場：エンドユーザー別

• クリニック
• ホームケア設定
• 病院

第12章 南北アメリカの経皮吸収パッチ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋の経皮吸収パッチ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの経皮吸収パッチ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • DifGen Pharmaceuticalsは、米国の製造拠点 AvevaドラッグデリバリーSystemsから2番目の製品であるブプレノルフィン経皮吸収システムを発売します。米国製の経皮吸収パッチおよび舌下フィルムの製造と販売のポートフォリオを拡大します。
  • Luye Pharma Ltdが英国で新たなアルツハイマー病治療を発売
  • コルセア・ファーマ、肺動脈性高血圧症の臨床試験を進めるため2,300万米ドルのシリーズB資金調達を発表
  • Vaxess、mRNAワクチンパッチ開発加速のため900万米ドルを調達
  • アルミラル、スペインでアルツハイマー病治療の販売権を4,500万ユーロで取得
  • コリウムとロータス製薬、革新的なアルツハイマー病治療「ADLARITY」のアジア複数市場での独占ライセンス契約を締結
  • デクスメデトミジン経皮パッチが術後疼痛管理に急遽承認
  • LTS、ソレル社のウェアラブル注射デバイス事業の買収により高分子ドラッグデリバリーへの参入を完了
  • BioNxt、パーキンソン病治療薬ロチゴチン経皮パッチの欧州臨床試験の承認を取得
  • バイオクスト社、パーキンソン病治療薬ロチゴチン経皮パッチの臨床試験契約を締結し、臨床サンプルの製造を開始
  • LTSローマンが無針出産専門企業への投資を主導
  • Tesa Labtec GmbHの買収はAdhexPharmaの成長の礎となる

企業一覧

• Novartis AG
• Luye Pharma Group Ltd
• Gedeon Richter Plc
• Johnson & Johnson Services, Inc.
• AbbVie Inc.
• Teva Pharmaceutical Industries Ltd.
• DifGen Pharmaceuticals LLC
• Zydus Group
• Bliss GVS Pharma Ltd.
• Sparsha Pharma International Pvt Ltd
• GlaxoSmithKline Plc
• LAVIPHARM GROUP HOLDING S.A.
• Purdue Pharma L.P.
• Nitto Denko Corporation
• UCB S.A.
• Corsair Pharma, Inc.
• Amneal Pharmaceuticals, Inc.
• Tesa SE by Beiersdorf AG
• Medherant Limited
• ALVOGEN
• AdhexPharma SAS
• Tapemark by LTS Lohmann Therapie-Systeme AG
• Icure Pharmaceutical Inc.
• ProSolus, Inc.
• Corium, Inc.
• Viatris Inc.
• Boehringer Ingelheim International GmbH
• Endo International plc
• BioNxt Solutions Inc.
• Bayer AG
• Nutriband Inc
• Teikoku Seiyaku Co., Ltd.
• Perrigo Company plc
• Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.

LIST OF FIGURES

• FIGURE 1. TRANSDERMAL PATCHES MARKET RESEARCH PROCESS
• FIGURE 2. TRANSDERMAL PATCHES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 21. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 27. TRANSDERMAL PATCHES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TRANSDERMAL PATCHES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TRANSDERMAL PATCHES MARKET DYNAMICS
• TABLE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER DRUG-IN-ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY RESERVOIR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER DRUG-IN-ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY BUPRENORPHINE TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NICOTINE TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OXYBUTYNIN TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CHEMICAL ENHANCERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ELECTRIC CURRENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MECHANICAL ARRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY THERMAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SMOKING REDUCTION & CESSATION AID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 54. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 86. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 92. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 109. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 127. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 151. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 164. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 170. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 176. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 182. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 188. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 194. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 195. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 197. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 198. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 200. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 206. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 212. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 218. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 219. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 220. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 221. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 222. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 224. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 225. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 226. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 227. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 228. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 230. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 236. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 242. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 248. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 254. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 260. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 266. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 272. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 284. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 285. TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 286. TRANSDERMAL PATCHES MARKET, FPNV POSITIONING MATRIX, 2023

The Transdermal Patches Market was valued at USD 8.57 billion in 2023, expected to reach USD 9.89 billion in 2024, and is projected to grow at a CAGR of 16.40%, to USD 24.84 billion by 2030.

Transdermal patches are adhesive patches that deliver medication through the skin, ensuring steady and controlled release into the bloodstream over time. They are essential due to their non-invasive nature, improved patient compliance, and ability to bypass the gastrointestinal system, which makes them suitable for patients with swallowing difficulties or specific medication requirements. Applications span from pain management and nicotine withdrawal to hormone replacement therapy and chronic disease treatment. The end-use scope primarily includes healthcare facilities, clinics, and home healthcare settings. Growth in the transdermal patch market is primarily driven by rising chronic disease prevalence, increasing adoption of transdermal drug delivery systems, and advancements in patch technology. Emerging opportunities lie in the integration of smart technologies like sensors for dosage monitoring and personalized medicine approaches targeting specific patient needs. Companies might benefit from investing in R&D for developing patches with multifunctional capabilities, such as patches that not only deliver medication but also monitor vital signs. Limitations include skin irritation issues, limited permeability to certain drugs, and variability in skin absorption among patients, which pose challenges to efficacy. Furthermore, regulatory approval for new transdermal systems is stringent due to safety concerns, potentially slowing down product launches. The market is highly competitive, with key players focusing on expanding portfolios and geographical presence. Innovation opportunities exist in biocompatible materials to improve patch adhesion and minimize skin reactions, and developing transdermal delivery options for biologics, which are currently underrepresented. Trends show a shift towards hybrid systems that combine transdermal patches with injectable components for a more comprehensive drug delivery method. The market's nature is dynamic, driven by technological advancements and evolving consumer preferences, making ongoing innovation and adaptation crucial for sustained growth and competitive advantage in the transdermal patch industry.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transdermal Patches Market

The Transdermal Patches Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increased use of transdermal patches to treat chronic conditions worldwide
  • Rising preference for controlled drug release and non-invasive drug delivery solutions
  • Growing number of government approvals for transdermal patches
• Market Restraints
  • High costs associated with transdermal patches
• Market Opportunities
  • Ongoing research and development for advanced and highly efficient transdermal drug delivery patches
  • Emerging advances in the formulation and manufacturing of transdermal patches
• Market Challenges
  • Limitations associated with transdermal drugs along with product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Transdermal Patches Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transdermal Patches Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transdermal Patches Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transdermal Patches Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transdermal Patches Market

A detailed market share analysis in the Transdermal Patches Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transdermal Patches Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transdermal Patches Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Transdermal Patches Market, highlighting leading vendors and their innovative profiles. These include Novartis AG, Luye Pharma Group Ltd, Gedeon Richter Plc, Johnson & Johnson Services, Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., DifGen Pharmaceuticals LLC, Zydus Group, Bliss GVS Pharma Ltd., Sparsha Pharma International Pvt Ltd, GlaxoSmithKline Plc, LAVIPHARM GROUP HOLDING S.A., Purdue Pharma L.P., Nitto Denko Corporation, UCB S.A., Corsair Pharma, Inc., Amneal Pharmaceuticals, Inc., Tesa SE by Beiersdorf AG, Medherant Limited, ALVOGEN, AdhexPharma SAS, Tapemark by LTS Lohmann Therapie-Systeme AG, Icure Pharmaceutical Inc., ProSolus, Inc., Corium, Inc., Viatris Inc., Boehringer Ingelheim International GmbH, Endo International plc, BioNxt Solutions Inc., Bayer AG, Nutriband Inc, Teikoku Seiyaku Co., Ltd., Perrigo Company plc, and Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc..

Market Segmentation & Coverage

This research report categorizes the Transdermal Patches Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Matrix, Multi-layer Drug-in-Adhesive, Reservoir, and Single-layer Drug-in-Adhesive.
• Based on Type, market is studied across Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Fentanyl Transdermal Patch, Nicotine Transdermal Patch, and Oxybutynin Transdermal Patch.
• Based on Technology, market is studied across Chemical Enhancers, Electric Current, Mechanical Arrays, and Thermal Ablation.
• Based on Application, market is studied across Hormonal Therapy, Overactive Bladder, Pain Relief, and Smoking Reduction & Cessation Aid.
• Based on Distribution Channel, market is studied across Offline and Online.
• Based on End Users, market is studied across Clinics, Home Care Settings, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increased use of transdermal patches to treat chronic conditions worldwide
    • 5.1.1.2. Rising preference for controlled drug release and non-invasive drug delivery solutions
    • 5.1.1.3. Growing number of government approvals for transdermal patches
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with transdermal patches
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development for advanced and highly efficient transdermal drug delivery patches
    • 5.1.3.2. Emerging advances in the formulation and manufacturing of transdermal patches
  • 5.1.4. Challenges
    • 5.1.4.1. Limitations associated with transdermal drugs along with product recalls
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Significant penetration of Multi-layer Drug-in-Adhesive patches
  • 5.2.2. Type: Extensive requirement for nicotine transdermal patches
  • 5.2.3. Technology: Utilization of chemical enhancers to improve transdermal patch efficacy
  • 5.2.4. Application: Expanding use of transdermal patches for hormonal therapy
  • 5.2.5. Distribution Channel: Proliferation of transdermal patches on eCommerce platforms
  • 5.2.6. End Users: Increasing prescription of transdermal patches in hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Transdermal Patches Market, by Product

• 6.1. Introduction
• 6.2. Matrix
• 6.3. Multi-layer Drug-in-Adhesive
• 6.4. Reservoir
• 6.5. Single-layer Drug-in-Adhesive

7. Transdermal Patches Market, by Type

• 7.1. Introduction
• 7.2. Buprenorphine Transdermal Patch
• 7.3. Clonidine Transdermal Patch
• 7.4. Fentanyl Transdermal Patch
• 7.5. Nicotine Transdermal Patch
• 7.6. Oxybutynin Transdermal Patch

8. Transdermal Patches Market, by Technology

• 8.1. Introduction
• 8.2. Chemical Enhancers
• 8.3. Electric Current
• 8.4. Mechanical Arrays
• 8.5. Thermal Ablation

9. Transdermal Patches Market, by Application

• 9.1. Introduction
• 9.2. Hormonal Therapy
• 9.3. Overactive Bladder
• 9.4. Pain Relief
• 9.5. Smoking Reduction & Cessation Aid

10. Transdermal Patches Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Offline
• 10.3. Online

11. Transdermal Patches Market, by End Users

• 11.1. Introduction
• 11.2. Clinics
• 11.3. Home Care Settings
• 11.4. Hospitals

12. Americas Transdermal Patches Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Transdermal Patches Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Transdermal Patches Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. DifGen Pharmaceuticals Launches A Second Product - Buprenorphine Transdermal System From Its U.S. Manufacturing Site Aveva Drug Delivery Systems; Expanding Its Portfolio Of Manufacturing & Marketing U.S. Made Transdermal Patches And Sublingual Films
  • 15.3.2. Luye Pharma Ltd Launches New Alzheimer's Treatment In The UK
  • 15.3.3. Corsair Pharma Announces USD 23 Million Series B Financing to Advance Clinical Trials in Pulmonary Arterial Hypertension
  • 15.3.4. Vaxess Raises USD 9 Million to Accelerate mRNA Vaccine Patch Development
  • 15.3.5. Almirall Acquires Rights To Distribute Alzheimer's Treatment In Spain For An Initial EUR 45 Million
  • 15.3.6. Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY in Multiple Markets Across Asia
  • 15.3.7. Dexmedetomidine Transdermal Patch Fast Tracked for Postop Pain Management
  • 15.3.8. LTS Completes its Entry into Large Molecule Drug Delivery with the Acquisition of the Sorrel Wearable Injection Device Business
  • 15.3.9. BioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson's Disease
  • 15.3.10. Bionxt Signs Clinical Study Agreement and Commences Manufacture of Clinical Samples for Study of Transdermal Rotigotine Patch for Parkinson's Disease
  • 15.3.11. LTS Lohmann Leads Investment in Needle-Free Delivery Specialist
  • 15.3.12. The Addition of Tesa Labtec GmbH Marks a Cornerstone in AdhexPharma's Growth Path

Companies Mentioned

• 1. Novartis AG
• 2. Luye Pharma Group Ltd
• 3. Gedeon Richter Plc
• 4. Johnson & Johnson Services, Inc.
• 5. AbbVie Inc.
• 6. Teva Pharmaceutical Industries Ltd.
• 7. DifGen Pharmaceuticals LLC
• 8. Zydus Group
• 9. Bliss GVS Pharma Ltd.
• 10. Sparsha Pharma International Pvt Ltd
• 11. GlaxoSmithKline Plc
• 12. LAVIPHARM GROUP HOLDING S.A.
• 13. Purdue Pharma L.P.
• 14. Nitto Denko Corporation
• 15. UCB S.A.
• 16. Corsair Pharma, Inc.
• 17. Amneal Pharmaceuticals, Inc.
• 18. Tesa SE by Beiersdorf AG
• 19. Medherant Limited
• 20. ALVOGEN
• 21. AdhexPharma SAS
• 22. Tapemark by LTS Lohmann Therapie-Systeme AG
• 23. Icure Pharmaceutical Inc.
• 24. ProSolus, Inc.
• 25. Corium, Inc.
• 26. Viatris Inc.
• 27. Boehringer Ingelheim International GmbH
• 28. Endo International plc
• 29. BioNxt Solutions Inc.
• 30. Bayer AG
• 31. Nutriband Inc
• 32. Teikoku Seiyaku Co., Ltd.
• 33. Perrigo Company plc
• 34. Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.